NCT01359787View on ClinicalTrials.gov

Efficacy and Safety of Different Concentrations of Mapracorat Ointment Over 4 Weeks in Atopic Dermatitis (AD)

PHASE2CompletedINTERVENTIONAL
Enrollment

197

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Atopic DermatitisEczema
Interventions
DRUG

Mapracorat

Daily topical application

DRUG

Vehicle without active

Daily topical application

Trial Locations (1)

10589

Berlin

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY